PolyI-poly(C12.U)sodium salt


Product Details

CAT No.# CS-CA-00213
Category Nucleotides
CAS 38640-92-5
Molecular Weight 995.59
Molecular Formula C28H40N9O25P3
Synonyms: ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-3H-purin-9(6H)-yl)tetrahydrofuran-2-yl)methyl dihydrogen phosphate compound with ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate and ((2R,3S,4R,????????????????????????????????????????????????????????????????????????????????????????????????????????????
Shipping: Free Shipping for worldwide on order above 2000 USD
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PolyI-poly(C12.U)sodium salt Worldwide Suppliers of PolyI-poly(C12.U)sodium salt Nucleotides Clearsynth CS-CA-00213

Product rating: 9 PolyI-poly(C12.U)sodium salt based on 20 ratings

  1. Nucleotides
  2. PolyI-poly(C12.U)sodium salt
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)

This page contains information about PolyI-poly(C12.U)sodium salt Cas 38640-92-5 and its Nucleotides.

PolyI-poly(C12.U)sodium salt PolyI-poly(C12.U)sodium salt Nucleotides of PolyI-poly(C12.U)sodium salt Nucleotides Clearsynth 38640-92-5 https://www.clearsynth.com/en/temp/CS-CA-00213.jpg

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."